Safety, pharmacokinetics, and immunogenicity of a co-formulated cocktail of three human monoclonal antibodies targeting Ebola virus glycoprotein in healthy adults: a randomised, first-in-human phase 1 study-Reference-Cited by-同舟云学术

Safety, pharmacokinetics, and immunogenicity of a co-formulated cocktail of three human monoclonal antibodies targeting Ebola virus glycoprotein in healthy adults: a randomised, first-in-human phase 1 study

Published:2018-08 Issue:8 Volume:18 Page:884-893
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Sivapalasingam Sumathi,Kamal Mohamed,Slim Rabih,Hosain Romana,Shao Weiping,Stoltz Randall,Yen Joseph,Pologe Laura G,Cao Yuan,Partridge Michael,Sumner Giane,Lipsich Leah

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference15 articles.

1. Ebola virus (EBOV) infection: therapeutic strategies;De Clercq;Biochem Pharmacol,2015

2. After Ebola in west Africa—unpredictable risks, preventable epidemics;WHO Team;N Engl J Med,2016

3. Risk factors for transmission of Ebola or Marburg virus disease: a systematic review and meta-analysis;Brainard;Int J Epidemiol,2016

4. Clinical illness and outcomes in patients with Ebola in Sierra Leone;Schieffelin;N Engl J Med,2014

5. The multiple roles of sGP in Ebola pathogenesis;de La Vega;Viral Immunol,2015

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevention and post-exposure management of occupational exposure to Ebola virus;The Lancet Infectious Diseases;2024-02

2. Ebola and Marburg viruses;Molecular Medical Microbiology;2024

3. Biomanufacturing of glycosylated antibodies: Challenges, solutions, and future prospects;Biotechnology Advances;2023-12

4. Filoviruses: Scientific Gaps and Prototype Pathogen Recommendation;The Journal of Infectious Diseases;2023-10-15

5. Ebola virus disease: A narrative review;Microbial Pathogenesis;2023-08